Ceapro Inc. Reports Financial Results for First Quarter 2024 and Provides Corporate Update

Stock Information for Ceapro Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Ceapro Inc.

Aeterna Zentaris and Ceapro Complete Merger Transaction
Canadian Investment Regulatory Organization Trading Halt - CZO
Ceapro Inc. Reports 2023 Financial Results and Operational Highlights
Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company
Ceapro Provides Business Update on Progress of Ongoing Development Programs, Technology and Cosmeceutical Base Business
Ceapro Inc. Announces the Mailing of Meeting Materials in Connection With the Special Meeting of Securityholders to Approve Merger With Aeterna Zentaris

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.